Gérald Raverot

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue et al. · The Lancet Diabetes & Endocrinology · 2014 · 395 citations

Medicine, Neurology, Pasireotide Versus

Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study

Adrian Daly, María A. Tichomirowa, Patrick Pétrossians et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 361 citations · Full text

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

Olivera Casar‐Borota, Philippe Chanson, Etienne Delgrange et al. · Endocrine Related Cancer · 2017 · 345 citations · Full text

Neuro-oncology, Anterior Pituitary, Pituitary Gland +14

Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families

Adrian F. Daly, Jean-François Vanbellinghen, Sok Kean Khoo et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 320 citations · Full text

Ketoconazole in Cushing's Disease: Is It Worth a Try?

Frédéric Castinetti, Laurence Guignat, Pauline Giraud et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 283 citations · Full text